Cargando…

Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis

AIMS/INTRODUCTION: Diabetes patients develop a variety of metabolic abnormalities in addition to hyperglycemia. However, details regarding change in various metabolites after comprehensive diabetes treatment remain unknown. This study aimed to identify the short‐term change in metabolome in inpatien...

Descripción completa

Detalles Bibliográficos
Autores principales: Taya, Naohiro, Katakami, Naoto, Omori, Kazuo, Arakawa, Shoya, Hosoe, Shigero, Watanabe, Hirotaka, Takahara, Mitsuyoshi, Miyashita, Kazuyuki, Nishizawa, Hitoshi, Matsuoka, Taka‐Aki, Furuno, Masahiro, Bamba, Takeshi, Iida, Junko, Fukusaki, Eiichiro, Shimomura, Iichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668060/
https://www.ncbi.nlm.nih.gov/pubmed/34032389
http://dx.doi.org/10.1111/jdi.13600
_version_ 1784614490413727744
author Taya, Naohiro
Katakami, Naoto
Omori, Kazuo
Arakawa, Shoya
Hosoe, Shigero
Watanabe, Hirotaka
Takahara, Mitsuyoshi
Miyashita, Kazuyuki
Nishizawa, Hitoshi
Matsuoka, Taka‐Aki
Furuno, Masahiro
Bamba, Takeshi
Iida, Junko
Fukusaki, Eiichiro
Shimomura, Iichiro
author_facet Taya, Naohiro
Katakami, Naoto
Omori, Kazuo
Arakawa, Shoya
Hosoe, Shigero
Watanabe, Hirotaka
Takahara, Mitsuyoshi
Miyashita, Kazuyuki
Nishizawa, Hitoshi
Matsuoka, Taka‐Aki
Furuno, Masahiro
Bamba, Takeshi
Iida, Junko
Fukusaki, Eiichiro
Shimomura, Iichiro
author_sort Taya, Naohiro
collection PubMed
description AIMS/INTRODUCTION: Diabetes patients develop a variety of metabolic abnormalities in addition to hyperglycemia. However, details regarding change in various metabolites after comprehensive diabetes treatment remain unknown. This study aimed to identify the short‐term change in metabolome in inpatients who were subject to comprehensive diabetes treatment, using gas chromatography/mass spectrometry‐based non‐target metabolomics techniques. MATERIALS AND METHODS: Participants of the present study were randomly recruited from the patients with type 2 diabetes hospitalized due to problems with glycemic control (n = 31) and volunteers without diabetes (n = 30), both of whom were aged between 20 and 75 years. A metabolomic analysis of fasting plasma samples on the 2nd (pre‐treatment) and 16th hospital (post‐treatment) day with gas chromatography/mass spectrometry using a multiple reaction monitoring mode was carried out. RESULTS: A principal component analysis showed that metabolome of fasting plasma was different between individuals with and without diabetes. The metabolome of fasting plasma in diabetes patients after treatment was different from that of pre‐treatment, as well as individuals without diabetes. Many amino acids (proline, glycine, serine, threonine, methionine, pyroglutamic acid, glutamine and lysine) were significantly increased by >10% after administering the inpatient diabetes treatment. A hierarchical clustering analysis showed that in the case of patients with markedly decreased monosaccharide levels and increased 1,5‐anhydroglucitol, the levels of amino acids increased more significantly. CONCLUSIONS: After a 2‐week comprehensive treatment, the plasma levels of various amino acids increased in conjunction with the reduction in monosaccharide levels in poorly controlled type 2 diabetes patients.
format Online
Article
Text
id pubmed-8668060
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86680602021-12-21 Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis Taya, Naohiro Katakami, Naoto Omori, Kazuo Arakawa, Shoya Hosoe, Shigero Watanabe, Hirotaka Takahara, Mitsuyoshi Miyashita, Kazuyuki Nishizawa, Hitoshi Matsuoka, Taka‐Aki Furuno, Masahiro Bamba, Takeshi Iida, Junko Fukusaki, Eiichiro Shimomura, Iichiro J Diabetes Investig Articles AIMS/INTRODUCTION: Diabetes patients develop a variety of metabolic abnormalities in addition to hyperglycemia. However, details regarding change in various metabolites after comprehensive diabetes treatment remain unknown. This study aimed to identify the short‐term change in metabolome in inpatients who were subject to comprehensive diabetes treatment, using gas chromatography/mass spectrometry‐based non‐target metabolomics techniques. MATERIALS AND METHODS: Participants of the present study were randomly recruited from the patients with type 2 diabetes hospitalized due to problems with glycemic control (n = 31) and volunteers without diabetes (n = 30), both of whom were aged between 20 and 75 years. A metabolomic analysis of fasting plasma samples on the 2nd (pre‐treatment) and 16th hospital (post‐treatment) day with gas chromatography/mass spectrometry using a multiple reaction monitoring mode was carried out. RESULTS: A principal component analysis showed that metabolome of fasting plasma was different between individuals with and without diabetes. The metabolome of fasting plasma in diabetes patients after treatment was different from that of pre‐treatment, as well as individuals without diabetes. Many amino acids (proline, glycine, serine, threonine, methionine, pyroglutamic acid, glutamine and lysine) were significantly increased by >10% after administering the inpatient diabetes treatment. A hierarchical clustering analysis showed that in the case of patients with markedly decreased monosaccharide levels and increased 1,5‐anhydroglucitol, the levels of amino acids increased more significantly. CONCLUSIONS: After a 2‐week comprehensive treatment, the plasma levels of various amino acids increased in conjunction with the reduction in monosaccharide levels in poorly controlled type 2 diabetes patients. John Wiley and Sons Inc. 2021-07-01 2021-12 /pmc/articles/PMC8668060/ /pubmed/34032389 http://dx.doi.org/10.1111/jdi.13600 Text en © 2021 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Articles
Taya, Naohiro
Katakami, Naoto
Omori, Kazuo
Arakawa, Shoya
Hosoe, Shigero
Watanabe, Hirotaka
Takahara, Mitsuyoshi
Miyashita, Kazuyuki
Nishizawa, Hitoshi
Matsuoka, Taka‐Aki
Furuno, Masahiro
Bamba, Takeshi
Iida, Junko
Fukusaki, Eiichiro
Shimomura, Iichiro
Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis
title Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis
title_full Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis
title_fullStr Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis
title_full_unstemmed Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis
title_short Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis
title_sort evaluation of change in metabolome caused by comprehensive diabetes treatment: a prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668060/
https://www.ncbi.nlm.nih.gov/pubmed/34032389
http://dx.doi.org/10.1111/jdi.13600
work_keys_str_mv AT tayanaohiro evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis
AT katakaminaoto evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis
AT omorikazuo evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis
AT arakawashoya evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis
AT hosoeshigero evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis
AT watanabehirotaka evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis
AT takaharamitsuyoshi evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis
AT miyashitakazuyuki evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis
AT nishizawahitoshi evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis
AT matsuokatakaaki evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis
AT furunomasahiro evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis
AT bambatakeshi evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis
AT iidajunko evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis
AT fukusakieiichiro evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis
AT shimomuraiichiro evaluationofchangeinmetabolomecausedbycomprehensivediabetestreatmentaprospectiveobservationalstudyofdiabetesinpatientswithgaschromatographymassspectrometrybasednontargetmetabolomicanalysis